African Stock Exchanges

IIL - Intravenous Infusions Limited

Twitter · Facebook
IIL share price on Ghana Stock ExchangeIIL share price on Ghana Stock Exchange

Intravenous Infusions Limited (IIL) is a Ghanaian pharmaceutical company and the market leader in the manufacture of intravenous infusions in the country. IIL was incorporated in 1969 and began operations in 1974 as the first pharmaceutical company producing intravenous infusions in Ghana. The company was set up to take advantage of the total lack of local production of infusions and the country's dependence on imports. Since then, IIL has grown to become the dominating market leader with a market share of about 50% in the country. The company also exports its products to the immediate neighboring countries, namely, Ivory Coast, Burkina Faso, and Togo. Intravenous Infusions Limited listed on the Ghana Alternative Market in December 2015.

Intravenous Infusions Limited is listed on the Ghana Stock Exchange (GSE). Intravenous Infusions is traded on the GSE under the ticker symbol “IIL”. The International Securities Identification Number (ISIN) of GSE:IIL is GH0000001258. Intravenous Infusions Limited is currently the 31st most valuable stock on the GSE with a market capitalization of GHS 10.4 million, which is about 0.017% of the Ghana Stock Exchange equity market.

IIL0.04 ▪ 0.00
3 days ago
Last Trading Results
Opening Price
Day’s Low Price
Day’s High Price
Traded Volume0
Number of Deals0
Gross Turnover0.00
Growth & Valuation
Earnings Per Share0.0044
Price/Earning Ratio9.09
Dividend Per Share0.00
Dividend Yield0%
Shares Outstanding259M
Market Capitalization10.4M
Monetary values are quoted in Ghana Cedi (GHS) unless otherwise stated

IIL Stock Market Performance

1WK4WK3MO
-20%
6MO1YRYTD
-20%-20%-20%

The current share price of Intravenous Infusions Limited (IIL) is GHS 0.04. IIL closed its last trading day (Wednesday, May 25, 2022) at 0.04 GHS per share on the Ghana Stock Exchange (GSE). Intravenous Infusions began the year with a share price of 0.05 GHS but has since lost 20% off that price valuation, ranking it 33rd on the GSE in terms of year-to-date performance.

Intravenous Infusions is the sixth most traded stock on the Ghana Stock Exchange over the past three months (Mar 24 - Jun 24, 2022). IIL has traded a total volume of 681,004 shares valued at GHS 27,240 over the period, with an average of 10,810 traded shares per session. A volume high of 604,555 was achieved on April 11th for the same period. The table below details the last 10 trading days of activity of Intravenous Infusions on the Ghana Stock Exchange.

DateVolumeCloseChangeChange%
2022-05-2523,9490.04
2022-04-1412,5000.04-0.01-20.00%
2022-04-1340,0000.05+0.01+25.00%
2022-04-11604,5550.04-0.01-20.00%
2022-03-15500.05
2021-12-302,0000.05
2021-12-09100,0000.05
2021-11-1810,0000.05
2021-10-2210,5000.05
2021-10-133,3340.05

Profile of Intravenous Infusions Limited

Intravenous Infusions Limited operates in the Health Care sector.

Factsheet of Intravenous Infusions Limited

Sector
Health Care
Industry
Address
Plot 4/7 BIKL, Adjacent Highways workshop, Akwadum Road, Effiduase-Koforidua
Telephone
+233-342-020-151

IIL Industrial Market Competitors

Intravenous Infusions Limited, issuers of the IIL stock on the Ghana Stock Exchange, have one market competitor who is also engaged in the Health Care sector. The table below presents an overview of their market standing.

CodeNameM. Cap.CloseYTD
DASPHARMADannex Ayrton Starwin Plc33.9M0.40

Index of African Stock Exchanges:

  1. Botswana Stock Exchange
  2. BRVM Stock Exchange
  3. Ghana Stock Exchange
  4. Johannesburg Stock Exchange
  5. Lusaka Securities Exchange
  6. Malawi Stock Exchange
  7. Nairobi Securities Exchange
  8. Nigerian Stock Exchange
  9. Uganda Securities Exchange
  10. Zimbabwe Stock Exchange

Comments (1)

  1. Rashidatu JaffaruRashidatu Jaffaru
    Mar 10, 2020 19:58 GMT

    I am a level 100 student of koforidua technical university can I do my attachment at your company

  • Showing 1 - 1 of 1
NOTE: You are replying to 's comment. [Cancel]